Hypertension, Vol 24, 758-762, Copyright © 1994 by American Heart Association
K Totsune, K Takahashi, O Murakami, F Satoh, M Sone, T Saito, H Sasano, T Mouri and K Abe
We studied the presence of three natriuretic peptides--atrial natriuretic
peptide (ANP), human brain natriuretic peptide (BNP), and C- type
natriuretic peptide (CNP)--in the human kidney by radioimmunoassay and
immunocytochemistry. Immunoreactive ANP, immunoreactive human BNP, and
immunoreactive CNP concentrations in six kidneys were 0.12 +/- 0.07 (mean
+/- SD), 0.23 +/- 0.08, and 0.37 +/- 0.07 pmol/g wet wt, respectively.
Sephadex G-50 superfine column chromatography and reversed-phase
high-performance liquid chromatography of kidney extracts revealed a broad
peak of immunoreactive ANP comigrating with ANP-28 and urodilatin. Renal
immunoreactive human BNP consisted of three components; the major component
comigrated with human BNP-32. Renal immunoreactive CNP consisted of at
least two components; the major component comigrated with CNP-22, and the
minor component eluted in a position similar to that of authentic human
CNP-53. Immunocytochemistry showed that immunoreactive human BNP was
colocalized with immunoreactive ANP in the segments of distal tubules,
whereas immunoreactive CNP was found predominantly in the proximal tubules.
These findings indicate that these three natriuretic peptides are present
in the human kidney and raise the possibility that they form a renal
natriuretic peptide system that participates in the local regulation of
sodium and water transport and renal circulation in the human kidney.
ARTICLES
Natriuretic peptides in the human kidney
Second Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.
This article has been cited by other articles:
![]() |
O. Lisy, B. K. Huntley, D. J. McCormick, P. A. Kurlansky, and J. C. Burnett Jr Design, Synthesis, and Actions of a Novel Chimeric Natriuretic Peptide: CD-NP. J. Am. Coll. Cardiol., July 1, 2008; 52(1): 60 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Lai, M. C. Hsieh, S. C. Hsin, S. R. Lin, J. Y. Guh, H. C. Chen, and S. J. Shin The Cellular Localization of Increased Atrial Natriuretic Peptide mRNA and Immunoreactivity in Diabetic Rat Kidneys J. Histochem. Cytochem., November 1, 2002; 50(11): 1501 - 1508. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cataliotti, M. Giordano, E. De Pascale, G. Giordano, P. Castellino, M. Jougasaki, L. C. Costello, G. Boerrigter, T. Tsuruda, P. Belluardo, et al. CNP production in the kidney and effects of protein intake restriction in nephrotic syndrome Am J Physiol Renal Physiol, September 1, 2002; 283(3): F464 - F472. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Boomsma and A. H. van den Meiracker Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use Cardiovasc Res, August 15, 2001; 51(3): 442 - 449. [Full Text] [PDF] |
||||
![]() |
T. Walther, H.-P. Schuitheiss, and C. Tschope Impaired angiotensin II regulation of renal C-type natriuretic peptide mRNA expression in experimental diabetes mellitus Cardiovasc Res, August 15, 2001; 51(3): 562 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.R Kalra, S.D Anker, A.D Struthers, and A.J.S Coats The role of C-type natriuretic peptide in cardiovascular medicine Eur. Heart J., June 2, 2001; 22(12): 997 - 1007. [PDF] |
||||
![]() |
I. Pham, S. Sediame, G. Maistre, F. Roudot-Thoraval, P.-E. Chabrier, A. Carayon, and S. Adnot Renal and vascular effects of C-type and atrial natriuretic peptides in humans Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1997; 273(4): R1457 - R1464. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |